News
Researchers find tirzepatide more effective than semaglutide for weight loss in a 72-week trial, with significant reductions ...
Zepbound was found to be more effective. Study participants using tirzepatide lost more weight after 72 weeks (average loss of 20.2% compared to 13.7% for semaglutide). This translates to an ...
Orforglipron (pronounced or-for-GLIP-ron) might be a mouthful to say, but Indianapolis-based Eli Lilly and Co. sees this ...
A clash is brewing between doctors and patients when it comes to treatment for sleep apnea in those with obesity, a new study ...
The percentage of adults prescribed a GLP-1 drug like Wegovy or Zepbound jumped almost sevenfold over the past five years, ...
Tirzepatide is now approved for the treatment of obstructive sleep apnea, highlighting the drug class' potential in sleep ...
The findings presented at a conference in Chicago found a slightly lower risk of obesity-related cancers when adults with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback